InspireMD (NSPR) Tops Q3 EPS by 4c

InspireMD (NASDAQ: NSPR) reported Q3 EPS of ($0.16), $0.04 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $1.81 million versus the consensus estimate of $1.74 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• UBS sees a negative catalyst ahead for Nike: Here’s what to watch
• Jackson Financial Inc. (JXN) call put ratio 1 call to 14.6 puts with a focus on September 130 and 135 puts as share price down 4.8%
• Freeport-McMoran (FCX) call put ratio 3 calls to 1 put with a focus on October calls as share price up 2.9%